Anebulo Pharmaceuticals, Inc. 10-K filing
Filed 2025-09-29 · Report date 2025-06-30 · 2025 FY
Filing metadata
- Accession number
- 0001493152-25-016015
- Form type
- 10-K
- CIK
- 0001815974
- Primary document
- https://www.sec.gov/Archives/edgar/data/1815974/000149315225016015/form10-k.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Anebulo Pharmaceuticals, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-9.2M | - | - |
| Net Income | $-8.5M | - | - |
| Eps Basic | -0.25 | - | - |
| Eps Diluted | -0.25 | - | - |
| Cash And Equivalents | $11.6M | - | - |
| Total Assets | $12.1M | - | - |
| Total Liabilities | $487,688 | - | - |
| Shareholders Equity | $11.7M | - | - |
| Operating Cash Flow | $-6.3M | - | - |